The Potential Rise in the Price of Pacira BioSciences Inc (PCRX) following insiders activity

Samantha Gray

Pacira BioSciences Inc’s filing revealed that its Chief Medical Officer SLONIN JONATHAN unloaded Company’s shares for reported $95396.0 on Nov 17 ’25. In the deal valued at $24.09 per share,3,960 shares were sold. As a result of this transaction, SLONIN JONATHAN now holds 178,367 shares worth roughly $4.13 million.

Then, SLONIN JONATHAN bought 3,960 shares, generating $95,396 in total proceeds.

Before that, Cross Shawn sold 12,060 shares. Pacira BioSciences Inc shares valued at $266,405 were divested by the Chief Financial Officer at a price of $22.09 per share. As a result of the transaction, Cross Shawn now holds 56,250 shares, worth roughly $1.3 million.

H.C. Wainwright initiated its Pacira BioSciences Inc [PCRX] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Truist’s analysts, who increased its forecast for the stock in late July from “a Hold” to “a Buy”. Truist also remained covering PCRX and has increased its forecast on January 30, 2025 with a “Hold” recommendation from previously “Sell” rating. Truist revised its rating on August 13, 2024. It rated PCRX as “a Sell” which previously was an “a Buy”.

Price Performance Review of PCRX

On Tuesday, Pacira BioSciences Inc [NASDAQ:PCRX] saw its stock jump 0.04% to $23.17. Over the last five days, the stock has lost -5.00%. Pacira BioSciences Inc shares have risen nearly 33.31% since the year began. Nevertheless, the stocks have risen 22.98% over the past one year. While a 52-week high of $27.64 was reached on 09/03/25, a 52-week low of $16.29 was recorded on 01/06/25.

Levels Of Support And Resistance For PCRX Stock

The 24-hour chart illustrates a support level at 22.79, which if violated will result in even more drops to 22.42. On the upside, there is a resistance level at 23.76. A further resistance level may holdings at 24.35.

How much short interest is there in Pacira BioSciences Inc?

A steep rise in short interest was recorded in Pacira BioSciences Inc stocks on 2025-11-14, growing by 1.33 million shares to a total of 7.28 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 5.95 million shares. There was a rise of 18.28%, which implies that there is a positive sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.